US Federal House Bill HJR74

US Federal 2025-2026 Regular Session

• Introduced: 3/6/25
• Refer: 3/6/25

Caption

Disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V)".

Summary

H.J. Res. 74 is a congressional disapproval resolution introduced under the Congressional Review Act to overturn a Consumer Financial Protection Bureau rule titled “Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V).” The resolution does not itself create a new regulatory framework; instead, it seeks to nullify the CFPB rule that limits how creditors and consumer reporting agencies may use medical information in credit-related decisions and reporting. If enacted, the resolution would prevent the CFPB rule from taking effect and would also bar the bureau from issuing a substantially similar rule in the future without new statutory authorization. In practical terms, the measure would affect federal consumer finance regulation, especially the treatment of medical debt and other medical information in credit underwriting, collections, and credit reporting practices. The bill was referred to the House Committee on Financial Services and, based on the available record, has not advanced further.

Impact

The resolution would directly affect federal administrative law by disapproving a CFPB regulation under the Congressional Review Act. Its main legal effect would be to invalidate the medical-information rule and limit the agency’s ability to reissue a substantially similar regulation absent new legislation. The affected parties would include creditors, consumer reporting agencies, and consumers whose medical information may be used or reported in connection with credit decisions, particularly those with medical debt or other health-related financial records.

Sentiment

The available record shows the resolution was introduced by a group of House Republicans and referred to committee, with no recorded committee debate or vote in the provided materials. Based on sponsorship and the nature of the measure, the general sentiment appears to be opposition to the CFPB’s medical-information rule and support for blocking it. No contrary views are documented in the supplied transcript or voting history.

Contention

The central point of contention is whether the CFPB should restrict the use of medical information in consumer credit reporting and lending. Supporters of the resolution appear to view the rule as an overreach by the bureau and an unnecessary constraint on creditors and credit bureaus, while opponents of disapproval would likely argue that the rule protects consumer privacy and reduces the harm caused by medical debt in credit markets. Because no committee transcript or vote is available, the specific arguments of each side are not documented in the provided record.